You are here

glioma

Agios to Receive $1.1B Following FDA Approval of Vorasidenib

Contract Pharma

Wed, 08/7/24 - 11:26 am

Agios Pharmaceuticals

Servier snags FDA approval for Voranigo, the 1st targeted therapy for a common type of brain tumor

Fierce Pharma

Tue, 08/6/24 - 05:57 pm

Ipsen builds again, licensing Day One glioma drug

Pharmaphorum

Thu, 07/25/24 - 11:10 am

Day One Biopharmaceuticals

US, EU regulators start swift reviews of Servier glioma drug

Pharmaphorum

Wed, 02/21/24 - 11:09 am

Servier’s vorasidenib proves efficacy in tumor growth reduction

Clinical Trials Arena

Mon, 11/20/23 - 10:09 am

clinical trials

ASCO: French Pharma's Drug Slows Tumors in Brain Cancer Patients

BioSpace

Mon, 06/5/23 - 10:00 pm

Novartis Combo could be New Standard of Care for Pediatric Glioma Patients

BioSpace

Wed, 06/8/22 - 10:42 am

clinical trials

Agios up as FDA gives Thermo Fisher glioma test breakthrough status

Pharmaforum

Tue, 06/16/20 - 10:35 am

Agios Pharmaceuticals

In surprise move, Pfizer hands back IDO1 inhibitor

Biopharma Dive

Sat, 01/6/18 - 12:29 pm

iTeos Therapeutics

Agenus: Buy Or Ready To Bust?

Seeking Alpha

Tue, 04/3/12 - 09:01 am

Antigenics launches trial for glioma vaccine

Bizjournals.com

Thu, 08/13/09 - 02:08 pm